|
“Receiving my cancer diagnosis was an emotional shock, which was then compounded by the immediate flood of information about treatment options and potential clinical trials. I was given the option of “waiting to see” if a recurrence happens in the future, or immediately starting immunotherapy with the current standard of care drug, Keytruda, or joining a clinical trial that combines Keytruda with a new drug. The explanations of potential benefits and risks were highly technical and, frankly, overwhelming without guidance from unbiased, knowledgeable medical experts. That is exactly what thesecondopinion provided. They reviewed my medical file and cancer diagnosis, answered my questions about the treatment options including potential clinical trials, and were essential in helping me understand the technical medical issues so I could make the best, informed decisions about my treatment. I can’t imagine going through this critical process without the help provided by thesecondopinion. – Rob, Cancer Patient
In the United States, there are over 10,000 active cancer clinical trials held each year. Approximately 25% of cancer patients choose to participate in these trials. Clinical trials can offer potential benefits, such as access to new treatments and the opportunity to contribute to medical research. However, they also come with risks and uncertainties. It's important to thoroughly understand the purpose, procedures, potential side effects, and possible outcomes of the trial before making a decision. Your healthcare provider can provide guidance based on your specific medical condition and individual circumstances.
For a closer look at the different phases of cancer clinical trials and some trusted resources for information and clinical trial searches, click here.
| 
